Literature DB >> 16524362

Effect of fatty acids on endothelium-dependent relaxation in the rabbit aorta.

Indika Edirisinghe1, Kellie McCormick Hallam, C Tissa Kappagoda.   

Abstract

The metabolic syndrome, Type II (non-insulin-dependent) diabetes and obesity are associated with endothelial dysfunction and increased plasma concentrations of NEFAs (non-esterified fatty acids; free fatty acids). The present study was undertaken to define the inhibitory effects of saturated NEFAs on EDR (endothelium-dependent relaxation). Experiments were performed in rings of rabbit aorta to establish (i) dose-response relationships, (ii) the effect of chain length, (iii) the effect of the presence of double bonds, (iv) reversibility and time course of inhibition, and (v) the effect on nitric oxide production. Aortic rings were incubated (1 h) with NEFA-albumin complexes derived from lauric (C(12:0)), myristic (C(14:0)), palmitic (C(16:0)), stearic (C(18:0)) and linolenic (C(18:3)) acids. EDR induced by acetylcholine (0.1-10 mumol/l) was measured after pre-contraction with noradrenaline. Inhibition of EDR was dose-dependent (0.5-2 mmol/l NEFA), and the greatest inhibition (51%) was observed with stearic acid (2 mmol/l). Lauric acid had the smallest inhibitory effect. The inhibitory effects were always reversible and were evident after 15 min of incubation. Linolenic acid caused a significantly lower inhibition of EDR than stearic acid. SOD (superoxide dismutase) restored the inhibitory effect caused by NEFAs, suggesting the involvement of ROS (reactive oxygen species) in removing nitric oxide. The nitric oxide concentration measured after exposure of the rings to acetylcholine was lower after incubation with NEFAs than with Krebs buffer alone. This finding is consistent with removal of nitric oxide by ROS. This claim was supported by the demonstration of increased concentrations of nitrated tyrosine in the rings incubated with NEFAs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524362     DOI: 10.1042/CS20060001

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  14 in total

1.  Vascular dysfunction in Type 2 diabetes: emerging targets for therapy.

Authors:  Yoonjung Park; Junxi Wu; Hanrui Zhang; Yong Wang; Cuihua Zhang
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-03

2.  Lipid Emulsions Containing Medium Chain Triacylglycerols Blunt Bradykinin-Induced Endothelium-Dependent Relaxation in Porcine Coronary Artery Rings.

Authors:  Said Amissi; Julie Boisramé-Helms; Mélanie Burban; Sherzad K Rashid; Antonio J León-González; Cyril Auger; Florence Toti; Ferhat Meziani; Valérie B Schini-Kerth
Journal:  Lipids       Date:  2017-01-02       Impact factor: 1.880

3.  Ceacam1 deletion causes vascular alterations in large vessels.

Authors:  Sonia M Najjar; Kelly J Ledford; Simon L Abdallah; Alexander Paus; Lucia Russo; Meenakshi K Kaw; Sadeesh K Ramakrishnan; Harrison T Muturi; Christian K Raphael; Sumona Ghosh Lester; Garrett Heinrich; Sandrine V Pierre; Ralf Benndorf; Veronika Kleff; Ayad A Jaffa; Emile Lévy; Guillermo Vazquez; Ira J Goldberg; Nicole Beauchemin; Rosario Scalia; Süleyman Ergün
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-06-25       Impact factor: 4.310

Review 4.  The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Authors:  Hanrui Zhang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-12-22       Impact factor: 17.165

Review 5.  Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus.

Authors:  Sazan Rasul; Ludwig Wagner; Alexandra Kautzky-Willer
Journal:  Endocrine       Date:  2012-07-21       Impact factor: 3.633

6.  Antiobesogenic role of endothelial nitric oxide synthase.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Vitam Horm       Date:  2014       Impact factor: 3.421

Review 7.  Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide.

Authors:  J David Symons; E Dale Abel
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

8.  Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.

Authors:  J David Symons; Shawna L McMillin; Christian Riehle; Jason Tanner; Milda Palionyte; Elaine Hillas; Deborah Jones; Robert C Cooksey; Morris J Birnbaum; Donald A McClain; Quan-Jiang Zhang; Derrick Gale; Lloyd J Wilson; E Dale Abel
Journal:  Circ Res       Date:  2009-04-02       Impact factor: 17.367

Review 9.  Regulation of obesity and insulin resistance by nitric oxide.

Authors:  Brian E Sansbury; Bradford G Hill
Journal:  Free Radic Biol Med       Date:  2014-05-28       Impact factor: 7.376

10.  Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex.

Authors:  Quan-Jiang Zhang; William L Holland; Lloyd Wilson; Jason M Tanner; Devin Kearns; Judd M Cahoon; Dix Pettey; Jason Losee; Bradlee Duncan; Derrick Gale; Christopher A Kowalski; Nicholas Deeter; Alexandrea Nichols; Michole Deesing; Colton Arrant; Ting Ruan; Christoph Boehme; Dane R McCamey; Janvida Rou; Kapil Ambal; Krishna K Narra; Scott A Summers; E Dale Abel; J David Symons
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.